◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Cannara Biotech Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q4 2025Nov 30, 2025 Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024 Q3 2024Aug 31, 2024 Q2 2024May 31, 2024
Total Revenue 30.1M 28.2M 27.3M 26.6M 25.1M -- --
Operating Revenue 42.8M 40.1M 38.8M 36.8M 35.9M -- --
Cost Of Revenue 18.9M 16.1M 14.5M 14.6M 14.9M -- --
Gross Profit 11.2M 12.1M 12.9M 12.0M 10.2M -- --
Selling General And Administration 8.0M 6.3M 5.7M 5.6M 5.5M -- --
General And Administrative Expense 5.2M 3.6M 3.2M 3.3M 3.3M -- --
Research And Development 287,449 191,153 176,944 171,446 171,689 -- --
Depreciation And Amortization In Income Statement 266,737 777,719 223,172 281,637 280,713 -- --
Other Operating Expenses -- -- -- -- -- -- -69,779
Operating Expense 8.5M 7.2M 6.1M 6.1M 5.9M -- --
Operating Income 2.7M 4.9M 6.8M 5.9M 4.2M -- --
EBIT 2.6M 5.3M 6.7M 5.7M 4.1M -- --
Interest Expense 608,113 805,267 937,596 1.0M 1.1M -- --
Interest Expense Non Operating 608,113 805,267 937,596 1.0M 1.1M -- --
Interest Income 82,701 89,577 62,187 67,763 61,415 -- --
Interest Income Non Operating 82,701 89,577 62,187 67,763 61,415 -- --
Net Interest Income -598,948 -787,224 -1.0M -1.1M -1.2M -- --
Other Income Expense -62,247 428,554 30,252 -22,166 -14,180 -- --
Special Income Charges 0.00 422,169 1,509 0.00 -1,209 -- --
Gain On Sale Of Security -62,247 6,385 28,743 -22,166 -12,971 -- --
Pretax Income 2.0M 4.5M 5.8M 4.7M 3.0M -- --
Tax Provision 1.0M 1.2M 1.7M 1.4M 728,051 -- --
Tax Effect Of Unusual Items -9,337 115,839 8,618 -6,631 -3,403 -- --
Net Income From Continuing And Discontinued Operation 1.0M 3.3M 4.1M 3.3M 2.3M -- --
Net Income From Continuing Operation Net Minority Interest 1.0M 3.3M 4.1M 3.3M 2.3M -- --
Net Income Including Noncontrolling Interests 1.0M 3.3M 4.1M 3.3M 2.3M -- --
Net Income Common Stockholders 1.0M 3.3M 4.1M 3.3M 2.3M -- --
Net Income 1.0M 3.3M 4.1M 3.3M 2.3M -- --
EBITDA 4.2M 7.6M 8.0M 7.4M 5.6M -- --
Normalized EBITDA 4.3M 7.1M 8.0M 7.4M 5.7M -- --
Reconciled Depreciation 1.6M 2.2M 1.3M 1.6M 1.6M -- --
Basic EPS 0.01 -- 0.05 0.04 0.03 -- 0.02
Diluted EPS 0.01 -- 0.04 0.04 0.03 -- 0.02
Basic Average Shares 93.7M -- 91.4M 90.6M 90.0M -- 90.0M
Diluted Average Shares 96.2M -- 92.6M 92.3M 91.6M -- 91.5M
Total Unusual Items -62,247 428,554 30,252 -22,166 -14,180 -- --
Total Unusual Items Excluding Goodwill -62,247 428,554 30,252 -22,166 -14,180 -- --
Tax Rate For Calcs 0.15 0.27 0.28 0.30 0.24 -- --
Normalized Income 1.1M 3.0M 4.1M 3.3M 2.3M -- --
Amortization 266,737 777,719 223,172 281,637 280,713 -- --
Amortization Of Intangibles Income Statement 266,737 777,719 223,172 281,637 280,713 -- --
Depreciation Amortization Depletion Income Statement 266,737 777,719 223,172 281,637 280,713 -- --
Diluted NI Availto Com Stockholders 1.0M 3.3M 4.1M 3.3M 2.3M -- --
Excise Taxes 12.7M 11.9M 11.5M 11.3M 10.9M -- --
Gain On Sale Of Ppe 0.00 422,169 1,509 0.00 -1,209 -- --
Net Income Continuous Operations 1.0M 3.3M 4.1M 3.3M 2.3M -- --
Net Non Operating Interest Income Expense -598,948 -787,224 -1.0M -1.1M -1.2M -- --
Other Gand A 2.1M 2.0M 1.7M 1.7M 1.8M -- --
Reconciled Cost Of Revenue 17.6M 14.7M 13.4M 13.3M 13.6M -- --
Rent Expense Supplemental 120,467 81,148 103,572 104,140 84,697 -- --
Salaries And Wages 3.1M 1.6M 1.4M 1.5M 1.5M -- --
Selling And Marketing Expense 2.7M 2.7M 2.6M 2.3M 2.2M -- --
Total Expenses 27.4M 23.3M 20.6M 20.7M 20.8M -- --
Total Operating Income As Reported 2.7M 5.3M 6.8M 5.9M 4.2M -- --
Total Other Finance Cost 73,536 71,534 125,711 174,442 195,915 -- --
Line Item Q4 2025Nov 30, 2025 Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024 Q3 2024Aug 31, 2024 Q2 2024May 31, 2024
Cash And Cash Equivalents 16.5M 14.4M 14.4M 5.1M 10.3M -- --
Cash Cash Equivalents And Short Term Investments 16.5M 14.4M 14.4M 5.1M 10.3M -- --
Cash Financial 16.5M 14.4M 14.4M 5.1M 10.3M -- --
Accounts Receivable 15.2M 14.1M 14.1M 15.6M 12.9M -- --
Receivables 15.2M 14.1M 14.1M 15.6M 12.9M -- --
Inventory 52.0M 51.3M 49.0M 45.4M 41.7M -- --
Other Current Assets 1.3M 2.4M 1.6M 4.3M 3.4M -- --
Current Assets 85.0M 82.2M 84.0M 75.2M 73.2M -- --
Gross PPE 115.4M 111.5M 111.0M 109.7M 108.3M -- --
Accumulated Depreciation -26.8M -25.2M -25.0M -23.5M -22.0M -- --
Net PPE 88.5M 86.3M 86.0M 86.2M 86.3M -- --
Total Non Current Assets 88.8M 86.5M 86.1M 86.2M 87.8M -- --
Total Assets 173.8M 168.6M 170.1M 161.4M 161.0M -- --
Current Debt 8.9M 13.0M 13.0M 14.5M 15.7M -- --
Current Debt And Capital Lease Obligation 9.1M 13.3M 13.3M 14.8M 16.0M -- --
Accounts Payable 12.2M 11.1M 12.3M 11.5M 11.8M -- --
Payables 22.2M 20.8M 21.2M 16.8M 20.1M -- --
Payables And Accrued Expenses 22.2M 20.8M 21.2M 16.8M 20.1M -- --
Current Deferred Revenue 125,386 133,256 133,256 432,330 425,359 -- --
Current Liabilities 31.5M 34.2M 34.6M 32.1M 36.5M -- --
Long Term Debt 25.6M 28.2M 34.0M 33.8M 32.7M -- --
Long Term Debt And Capital Lease Obligation 25.7M 28.3M 34.1M 34.1M 33.0M -- --
Long Term Capital Lease Obligation 49,711 114,804 178,408 251,300 329,171 -- --
Total Non Current Liabilities Net Minority Interest 31.1M 32.2M 36.9M 35.2M 33.9M -- --
Total Liabilities Net Minority Interest 62.6M 66.4M 71.5M 67.2M 70.4M -- --
Common Stock 97.2M 89.8M 89.8M 89.8M 88.5M -- --
Capital Stock 97.2M 89.8M 89.8M 89.8M 88.5M -- --
Additional Paid In Capital 12.8M 12.3M 12.0M 11.7M 12.6M -- --
Retained Earnings 1.2M 178,280 -3.1M -7.3M -10.6M -- --
Gains Losses Not Affecting Retained Earnings -- -- -- -- -- 0.00 -69,291
Other Equity Adjustments -- -- -- -- -- -- -69,291
Common Stock Equity 111.2M 102.2M 98.6M 94.2M 90.6M -- --
Stockholders Equity 111.2M 102.2M 98.6M 94.2M 90.6M -- --
Total Equity Gross Minority Interest 111.2M 102.2M 98.6M 94.2M 90.6M -- --
Total Capitalization 136.8M 130.4M 132.6M 128.0M 123.3M -- --
Net Tangible Assets 111.2M 102.2M 98.6M 94.2M 90.6M -- --
Tangible Book Value 111.2M 102.2M 98.6M 94.2M 90.6M -- --
Working Capital 53.5M 48.0M 49.4M 43.2M 36.7M -- --
Invested Capital 145.7M 143.4M 145.6M 142.5M 138.9M -- --
Total Debt 34.8M 41.6M 47.5M 48.9M 49.0M -- --
Net Debt 18.0M 26.8M 32.6M 43.3M 38.1M -- --
Share Issued 94.9M 91.4M 91.4M 91.4M 90.0M -- --
Ordinary Shares Number 94.9M 91.4M 91.4M 91.4M 90.0M -- --
Assets Held For Sale Current -- 0.00 5.0M 4.9M 4.9M 4.9M --
Buildings And Improvements 77.8M 77.8M 77.3M 77.4M 77.3M -- --
Capital Lease Obligations 322,579 395,962 468,948 553,635 626,701 -- --
Construction In Progress 7.5M 4.9M 5.8M 5.5M 5.3M -- --
Current Capital Lease Obligation 272,868 281,158 290,540 302,335 297,530 -- --
Current Deferred Liabilities 125,386 133,256 133,256 432,330 425,359 -- --
Finished Goods 7.6M 6.9M 6.9M 4.5M 4.3M -- --
Land And Improvements 2.3M 2.3M 2.3M 2.3M 2.3M -- --
Line Of Credit 6.8M 6.8M 6.8M 6.8M 6.8M -- --
Machinery Furniture Equipment 26.7M 25.5M 24.5M 23.4M 22.4M -- --
Non Current Deferred Assets 131,675 52,164 0.00 0.00 1.2M -- --
Non Current Deferred Liabilities 5.5M 3.9M 2.7M 1.1M 915,930 -- --
Non Current Deferred Revenue 1.4M 878,220 894,104 900,326 915,930 -- --
Non Current Deferred Taxes Assets -- 0.00 0.00 0.00 1.2M 2.0M --
Non Current Deferred Taxes Liabilities 4.1M 3.1M 1.8M 188,392 -- 0.00 --
Non Current Prepaid Assets 159,160 159,160 132,073 46,323 256,323 -- --
Other Current Borrowings 2.1M 6.3M 6.3M 7.7M 8.9M -- --
Other Inventories 5.9M 6.8M 7.4M 6.2M 5.6M -- --
Other Properties 1.0M 1.0M 1.0M 1.0M 1.0M -- --
Properties 0.00 0.00 0.00 0.00 0.00 -- --
Raw Materials 27.0M 27.2M 25.8M 26.0M 23.5M -- --
Total Tax Payable 10.0M 9.7M 8.9M 5.3M 8.3M -- --
Work In Process 11.4M 10.4M 8.8M 8.7M 8.3M -- --
Line Item Q4 2025Nov 30, 2025 Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024 Q3 2024Aug 31, 2024 Q2 2024May 31, 2024
Operating Cash Flow 8.0M 2.8M 13.9M -2.6M 5.8M -- --
Cash Flow From Continuing Operating Activities 8.0M 2.8M 13.9M -2.6M 5.8M -- --
Depreciation And Amortization 1.6M 2.2M 1.3M 1.6M 1.6M -- --
Depreciation Amortization Depletion 1.6M 2.2M 1.3M 1.6M 1.6M -- --
Stock Based Compensation 1.7M 313,951 262,772 295,168 321,404 -- --
Deferred Tax 1.0M 1.2M 1.7M 1.4M 728,051 -- --
Deferred Income Tax 1.0M 1.2M 1.7M 1.4M 728,051 -- --
Change In Working Capital -163,326 -4.2M 6.5M -9.0M 332,200 -- --
Changes In Account Receivables -1.1M -11,374 1.5M -2.6M 123,360 -- --
Change In Receivables -1.1M 389,527 1.6M -2.5M 123,360 -- --
Change In Inventory -2.9M -2.0M -2.5M -2.7M -1.3M -- --
Change In Payables And Accrued Expense 2.3M -1.7M 5.1M -3.2M 1.8M -- --
Change In Payable 2.3M -1.7M 5.1M -3.2M 1.8M -- --
Change In Other Working Capital 512,729 -15,884 -305,296 -8,633 261,509 -- --
Other Non Cash Items 2.8M 315,286 50,389 -219,211 592,158 -- --
Capital Expenditure -4.6M -1.5M -2.2M -1.5M -1.2M -- --
Purchase Of PPE -4.6M -1.5M -2.2M -1.5M -1.2M -- --
Net PPE Purchase And Sale -4.6M -1.3M -2.2M -1.5M -1.2M -- --
Investing Cash Flow -4.6M -1.2M -2.1M -1.4M -1.2M -- --
Cash Flow From Continuing Investing Activities -4.6M -1.2M -2.1M -1.4M -1.2M -- --
Issuance Of Debt 0.00 0.00 0.00 0.00 500,000 -- --
Repayment Of Debt -654,421 -655,117 -1.7M -162,339 -599,286 -- --
Net Issuance Payments Of Debt -654,421 -655,117 -1.7M -162,339 -99,286 -- --
Repurchase Of Capital Stock -- 0.00 0.00 0.00 0.00 0.00 --
Net Common Stock Issuance -- 0.00 0.00 0.00 0.00 0.00 --
Common Stock Payments -- 0.00 0.00 0.00 0.00 0.00 --
Financing Cash Flow -1.2M -1.6M -2.4M -1.3M -1.0M -- --
Cash Flow From Continuing Financing Activities -1.2M -1.6M -2.4M -1.3M -1.0M -- --
Effect Of Exchange Rate Changes -- -- -- -- -- 0.00 0.00
Changes In Cash 2.2M -47,553 9.4M -5.2M 3.6M -- --
Beginning Cash Position 14.4M 14.4M 5.1M 10.3M 6.6M -- --
End Cash Position 16.5M 14.4M 14.4M 5.1M 10.3M -- --
Free Cash Flow 3.3M 1.4M 11.7M -4.0M 4.6M -- --
Cash Dividends Paid 0.00 0.00 0.00 0.00 0.00 -- --
Change In Account Payable 1.9M -2.1M 1.7M -141,718 1.0M -- --
Change In Income Tax Payable 337,428 406,984 3.4M -3.0M 748,632 -- --
Change In Prepaid Assets 1.0M -823,488 2.6M -643,082 -566,204 -- --
Change In Tax Payable 337,428 406,984 3.4M -3.0M 748,632 -- --
Depreciation 1.6M 2.2M 1.3M 1.6M 1.6M -- --
Gain Loss On Investment Securities -- 0.00 -- 26,764 -- 0.00 --
Gain Loss On Sale Of PPE 0.00 126,666 -1,509 0.00 1,209 -- --
Interest Paid Cff -511,291 -636,792 -747,841 -906,154 -920,540 -- --
Interest Received Cfi 59,581 82,768 54,466 72,016 40,362 -- --
Long Term Debt Issuance -- -- -- 0.00 -- -- --
Long Term Debt Payments -654,421 -653,819 -1.7M -162,339 -599,286 -- --
Net Income From Continuing Operations 1.0M 3.3M 4.1M 3.3M 2.3M -- --
Net Long Term Debt Issuance -654,421 -653,819 -1.7M -162,339 -599,286 -- --
Net Other Financing Charges -79,511 -339,578 -- -190,620 -- -449,517 -30,000
Net Other Investing Changes -- -- -- -- -- -86.00 2.1M
Net Short Term Debt Issuance 0.00 -1,298 0.00 -- 500,000 0.00 --
Operating Gains Losses -- -422,169 -1,509 26,764 1,209 0.00 --
Proceeds From Stock Option Exercised -- -- -- -- -- 0.00 0.00
Sale Of PPE 0.00 140,001 15,911 0.00 3,068 -- --
Short Term Debt Issuance 0.00 0.00 0.00 -- 500,000 0.00 --
Short Term Debt Payments -- -1,298 0.00 -- -- 0.00 -2.4M
NEWS
Loading news...
TRENDING
Loading...